247 related articles for article (PubMed ID: 24740447)
1. Tacrolimus-related adverse effects in liver transplant recipients: its association with trough concentrations.
Varghese J; Reddy MS; Venugopal K; Perumalla R; Narasimhan G; Arikichenin O; Shanmugam V; Shanmugam N; Srinivasan V; Jayanthi V; Rela M
Indian J Gastroenterol; 2014 May; 33(3):219-25. PubMed ID: 24740447
[TBL] [Abstract][Full Text] [Related]
2. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
[TBL] [Abstract][Full Text] [Related]
3. Clinically Significant Drug Interaction Between Clotrimazole and Tacrolimus in Pancreas Transplant Recipients and Associated Risk of Allograft Rejection.
Viesselmann CW; Descourouez JL; Jorgenson MR; Radke NA; Odorico JS
Pharmacotherapy; 2016 Mar; 36(3):335-41. PubMed ID: 26877191
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism of the CYP3A5 gene and its effect on tacrolimus blood level.
Nair SS; Sarasamma S; Gracious N; George J; Anish TS; Radhakrishnan R
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():197-200. PubMed ID: 25894154
[TBL] [Abstract][Full Text] [Related]
5. Clinical Efficacy and Safety of Tacrolimus in Pakistani Living Donor Liver Transplant Recipients.
Azam F; Khan M; Bhatti ABH; Dar FS; Ahmad A; Javed N
J Coll Physicians Surg Pak; 2019 Nov; 29(11):1048-1052. PubMed ID: 31659960
[TBL] [Abstract][Full Text] [Related]
6. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
Kim SH; Lee SD; Kim YK; Park SJ
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients.
Richards KR; Hager D; Muth B; Astor BC; Kaufman D; Djamali A
Transplantation; 2014 May; 97(10):986-91. PubMed ID: 24784360
[TBL] [Abstract][Full Text] [Related]
8. Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months.
Ramirez CB; Doria C; di Francesco F; Iaria M; Kang Y; Marino IR
J Surg Res; 2007 Apr; 138(2):198-204. PubMed ID: 17292404
[TBL] [Abstract][Full Text] [Related]
9. Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation.
Lo A; Egidi MF; Gaber LW; Shokouh-Amiri MH; Nazakatgoo N; Fisher JS; Gaber AO
Clin Transplant; 2004 Feb; 18(1):53-61. PubMed ID: 15108771
[TBL] [Abstract][Full Text] [Related]
10. Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients.
Naicker D; Reed PW; Ronaldson J; Kara T; Wong W; Prestidge C
Pediatr Nephrol; 2017 Nov; 32(11):2125-2131. PubMed ID: 28660366
[TBL] [Abstract][Full Text] [Related]
11. Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: A systematic review.
Braithwaite HE; Darley DR; Brett J; Day RO; Carland JE
Transplant Rev (Orlando); 2021 Apr; 35(2):100610. PubMed ID: 33756310
[TBL] [Abstract][Full Text] [Related]
12. African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipients.
Taber DJ; Gebregziabher MG; Srinivas TR; Chavin KD; Baliga PK; Egede LE
Pharmacotherapy; 2015 Jun; 35(6):569-77. PubMed ID: 26011276
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
Spence MM; Nguyen LM; Hui RL; Chan J
Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients.
Katari SR; Magnone M; Shapiro R; Jordan M; Scantlebury V; Vivas C; Gritsch A; McCauley J; Starzl T; Demetris AJ; Randhawa PS
Clin Transplant; 1997 Jun; 11(3):237-42. PubMed ID: 9193849
[TBL] [Abstract][Full Text] [Related]
15. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
Song GW; Lee SG; Hwang S; Kim KH; Kim WJ; Sin MH; Yoon YI; Tak EY
Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646
[TBL] [Abstract][Full Text] [Related]
16. A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation.
Staatz CE; Taylor PJ; Lynch SV; Tett SE
Liver Transpl; 2004 Apr; 10(4):506-12. PubMed ID: 15048793
[TBL] [Abstract][Full Text] [Related]
17. Identification of Factors Affecting Tacrolimus Trough Levels in Latin American Pediatric Liver Transplant Patients.
Riva N; Woillard JB; Distefano M; Moragas M; Dip M; Halac E; Cáceres Guido P; Licciardone N; Mangano A; Bosaleh A; de Davila MT; Schaiquevich P; Imventarza O
Liver Transpl; 2019 Sep; 25(9):1397-1407. PubMed ID: 31102573
[TBL] [Abstract][Full Text] [Related]
18. Adverse Effects of Tacrolimus and Its Associated Risk Factors in Renal Transplant Recipients.
Meera M; Manikandan S; Parameswaran S
Exp Clin Transplant; 2023 Jan; 21(1):22-27. PubMed ID: 36757165
[TBL] [Abstract][Full Text] [Related]
19. Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity.
Hariharan S; Munda R; Cavallo T; Demmy AM; Schroeder TJ; Alexander JW; First MR
Transplantation; 1996 Apr; 61(8):1161-5. PubMed ID: 8610411
[TBL] [Abstract][Full Text] [Related]
20. Redefining Therapeutic Drug Monitoring of Tacrolimus in Patients Undergoing Liver Transplantation: A Target Trough Concentration of 4-7 ng/mL During the First Month After Liver Transplantation is Safe and Improves Graft and Renal Function.
Lemaitre F; Tron C; Renard T; Jézéquel C; Houssel-Debry P; Bergeat D; Pastoret C; Collet N; Petitcollin A; Verdier MC; Bardou-Jacquet E; Camus C; Boudjema K; Bellissant E; Rayar M
Ther Drug Monit; 2020 Oct; 42(5):671-678. PubMed ID: 32941395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
